EDIT 8-K: SEC filing

Editas Medicine

Filed with the SEC on Nov 9, 2026 · accession 0001650664-26-000100

EDIT filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Editas Medicine issued a press release announcing financial results for the fiscal quarter ended September 30, 2026, along with other business highlights, furnished under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantEditas Medicine, Inc.

Chief financial officerAmy Parison

✦ Ask GOAX AI about this filing — what it means for EDIT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for EDIT?

Click here

Frequently asked questions

What did EDIT file with the SEC on Nov 9, 2026?

EDIT filed a 8-K (SEC filing). Editas Medicine issued a press release announcing financial results for the fiscal quarter ended September 30, 2026, along with other business highlights, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other EDIT SEC filings

Get alerts when EDIT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

EDIT overview EDIT analysis EDIT news Latest SEC filings